Kimberly-Clark prepares asset sales for EU approval of Kenvue deal, sources say
The company is reportedly readying concessions tied to EU antitrust concerns around its Kenvue bid after an initial review, according to sources.
Story updates
11:22:53 AM UTC
SquawkNews
Kenvue, Inc. (NYSE:KVUE) faces EU antitrust scrutiny tied to Kimberly—Clark’s ~$40B takeover, prompting concession planning, while the company also declared a $0.21 quarterly dividend and urged the 2nd U.S. Circuit to reconsider reviving 500+ Tylenol suits alleging pregnancy links to autism/ADHD.Pr…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.